Aspect Biosystems raised $115 million in a Series B round led by Dimension to advance bioprinted tissue therapeutics for serious metabolic and endocrine diseases.
Amount Raised
$115 Million
Round Type
Series B
VancouverBiotechnologyHealth CareInvestors
Description
Aspect Biosystems, a biotechnology company, has closed a $115 million Series B financing round. The funds will help advance bioprinted tissue therapeutics towards clinical applications and expand their tissue therapeutic platform.
Quick answer
Aspect Biosystems raised $115 Million in a Series B round, dated January 8, 2025. Investors: Rhino Ventures, Pangaea Ventures, In Bc, Novo Nordisk, Radical Ventures, Novo Nordisk A/S, InBC and T1D Fund. Aspect Biosystems is based in Vancouver, British Columbia, Canada.
- How much did Aspect Biosystems raise?
- Aspect Biosystems raised $115 Million in a Series B round on January 8, 2025.
- Who invested in Aspect Biosystems?
- Rhino Ventures, Pangaea Ventures, In Bc, Novo Nordisk, Radical Ventures, Novo Nordisk A/S, InBC and T1D Fund are named as investors in this round.
- What does Aspect Biosystems do?
- Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
- Where is Aspect Biosystems based and how big is it?
- Aspect Biosystems is based in Vancouver, British Columbia, Canada. Fundz records about 110 employees.
- Who are the decision-makers at Aspect Biosystems?
- Fundz holds 2 contacts at Aspect Biosystems, including the Head of Quality Control and Analytical Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Aspect Biosystems that raised within 45 days of this round, from Fundz verified event records.
- Ceretas raised $1M (Seed) on February 21, 2025.
- Humane Genomics raised an undisclosed amount (Seed) on February 21, 2025.
- Noah Labs raised $3.1M (Seed) on February 20, 2025.
- Impulse Dynamics raised $84M on February 20, 2025.
- Reverb Therapeutics raised $12M (Seed) on February 19, 2025.
- Level Zero Health raised $6.9M (Pre-Seed) on February 19, 2025.
Who to call at Aspect Biosystems, and when
A new round usually means Aspect Biosystems is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aspect Biosystems raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aspect Biosystems, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspect Biosystems. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspect Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAspect Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.